Akademiliv

Sahlgrenska akademins nyheter

På Svenska
University of Gothenburg Logotype
  • News
  • Notices
  • Calendar
  • Grants
  • About Akademiliv

Stem cells can become a treatment for common joint disease

20 June, 2022

RESEARCH COOPERATION. In the future, it is hoped that stem cells can be used to treat osteoarthritis, the world’s most common joint disease. Research is proceeding within AutoCRAT, a major European collaboration where the University of Gothenburg is one of the partners. Recently, members of AutoCRAT gathered for a plenary meeting at the Wallenberg Conference Center.

Arthritis, or osteoarthritis as the disease is also called, is a chronic disease that affects one out of four Swedes over the age of 45. Treatment currently consists mainly of physiotherapy and pain relief, but there is no cure for the disease.

At the end of last week, members of AutoCRAT gathered for a working meeting in the conference center Wallenberg. Click to see a larger image.

Within a large European research collaboration, work is underway to make it possible to use stem cells to rebuild cartilage tissue that has been worn out. The research collaboration, known as AutoCRAT, has four years of funding from the European Union (EU). The collaboration includes researchers at universities, research institutes, and companies in Ireland, Italy, the Netherlands, Sweden, and Germany.

Stem cell-based treatment

Kristina Vukusic, a researcher at the University of Gothenburg, leads the Swedish part of the EU project.

Kristina Vukusic

“In AutoCRAT we develop new stem cell-based products, all of which have the potential to become a future treatment. Soon we need to agree within the project on which alternative is most likely to become a cell therapy for osteoarthritis, which we will test next year in a large animal model.”

Josefin Ekholm has been working for a long time to develop new protocols for differentiation of IPS cells into chondrocytes.

The first option being investigated in the EU project is mesenchymal stem cells, a type of adult stem cell taken from adipose tissue or bone marrow. Another track is induced pluripotent stem cells, IPS, which is a method of inducing adult cells to become stem cells again. These cells can then be reprogrammed into cartilage cells, which can provide large amounts of cells that could serve the need ofmany patients. The third track concerns what are known as extracellular vesicles. These vesicles are small spheres of biological information that separate from the surface of the cell. They act as messengers between cells and may control the growth of cartilage cells or reduce inflammation in joints.

“Our research team in Gothenburg has extensive clinical experience cell therapy and has long been repairing cartilage. We assist the AutoCRAT project by providing cartilage cells that the end product can be compared with. We cultivate cartilage cells and examine their extracellular vesicles. For many years, we have developed new protocols where we differentiate IPS cells to become chondrocytes. In this way we hope to produce a universal donor for osteoarthritis patients.”

Inflammatory disease

Anders Lindahl, a professor at the University of Gothenburg and senior researcher in the EU projectAutoCRAT, was one of the first in the world to start working with cell therapy. In the early 1990s, he and his colleagues began treating patients with cartilage damage with the patient’s own cells. That treatment has become an approved cell therapy, which thousands of patients have received. Unfortunately, this form of treatment only works for patients with an isolated cartilage injury where there is healthy cartilage available and where the patient can be their own cell donor.

Anders Lindahl

“The protocol that we are developing describes in great detail how to handle the cells during the differentiation to achieve the desired result. The collaboration within AutoCRAT will then lead to optimal automatic production, where a cell culture robot replaces expensive laboratory premises and high personnel costs. The goal is to produce large amounts of cells and functional extracellular vesicles with a protocol that makes it possible to treat a large number of patients suffering from osteoarthritis,” says Lindahl.

OSTEOARTHRITIS FACTS

  • Osteoarthritis occurs when the cartilage in the joint gradually wears out. People with osteoarthritis have pain in individual joints, usually in the knees and often when they bear a heavy load.
  • Osteoarthritis is the world’s most common joint disease. In Sweden, one out of four adults over the age of 45 has osteoarthritis, and the disease is most common among the elderly and women. It is a chronic disease that breaks down the tissue of the joints.
  • Injuries, heredity, heavy work, and obesity are some of the causes. The disease can affect all joints in the body, but the knees and hips are most commonly afflicted. Osteoarthritis cannot be cured, but the right treatment can relieve the discomfort and pain.

BY: ELIN LINDSTRÖM

 

By: Elin Lindström

Add your own events in the Akademiliv Calendar

Johan Reutfors: Risk factors and consequences in difficult-to-treat depression – results from Swedish registry studies

Hybrid meeting – in Assembly Room Birgit Thilander (NOTE the venue!) or online via Zoom.

  • Hybrid webinar 15:00-16:00, Thursday June 8th.
  • Link to Zoom webinar.
  • Sahlgrenska Academy Science Seminars – see full program in the Staff Portal.

Information from Sahlgrenska Academy Research Support Office

[UPDATED MAY 23]
The Sahlgrenska Academy Research Support Office provides an overview of upcoming and current calls, nominations and events in an information letter. This letter is updated approximately four times per semester.

’20 minutes for researchers’ is back – see full spring program

During 20 minutes over Zoom, the Biomedical Library gives tips on tools and services that can facilitate your research everyday life.

Akademistatistik helps you with your statistics

Akademistatistik offers statistical and health-economic expertise to researchers and PhD students working at Sahlgrenska Academy and in the Region Västra Götaland. Here you can get advise in all aspects, from project formulation to the analyses required for journal publication.

  • If you want to make an appointment please use their online booking system.
  • Further information on Akademistatistik can be found on their homepage.

We are building at Medicinareberget

You will now find comprehensive information on construction projects that affect the Sahlgrenska Academy in the Staff Portal.

Lunch menus

Café Anatomen
Menu not available on website.

Café Annedal
Menu not available on website.

Lunchen.nu

Lustgården på Änggårdsbacken
Take away for external guests between 11.00-12.30 weekdays.

Lyktan

Mersmak Mölndal

Mersmak Sahlgrenska

Mersmak Östra

Salt & Syra

More news

High distinction for rheumatology research

2 June, 2023

DISTINCTION. The Department of Rheumatology and Inflammation Research at the Institute of Medicine, University of Gothenburg, has been designated …  

Unhealthy food dominated grocery store flyers

31 May, 2023

NEW STUDY. Unhealthy food dominated the weekly grocery store flyers. As much as two thirds of the space was taken up by less healthy foods …  

Magnus Gisslén new Chief Epidemiologist at Public Health Agency

31 May, 2023

POSITIONS. Magnus Gisslén, Professor of Infectious Diseases at the University of Gothenburg, is to be the Government’s new Chief Epidemiologist at …  

Congratulations to Kaj Blennow on high world ranking in neuroscience

30 May, 2023

DISTINCTION. Kaj Blennow, Professor of Clinical Neurochemistry at the University of Gothenburg, ranks 17th worldwide among all researchers in …  

Blood tests can show brain impact of neurosurgery

30 May, 2023

NEW STUDY. Damage to the brains of patients operated on for brain tumors may be assessed by measuring biomarkers in the blood pre- and …  

New method clarifies interplay between proteins and DNA

29 May, 2023

NEW STUDY. A research group at the University of Gothenburg has developed a method that makes the exact binding sites of specific proteins in the …  

Recipients of ALF educational grants

29 May, 2023

EDUCATIONAL DEVELOPMENT. We now know who has been awarded educational ALF grants for the 2023–2024 medical program and educational ALF grants for …  

See the pictures from the awarding of the Assar Gabrielsson prize in 2023

29 May, 2023

AWARDS. Assar Gabrielsson's prize is awarded for 2023 to two excellent doctoral theses in cancer research within Region Västra Götaland. Now you c …  

Vulvovaginal symptoms common in women taking penicillin

29 May, 2023

NEW DOCTORAL THESIS. Markedly often, women who take penicillin for strep throat suffer from vulvovaginal symptoms, and in both sexes, diarrhea is …  

Major investment in innovation cluster energizes GoCo House inauguration

26 May, 2023

COLLABORATION. With applause and gold confetti, GoCo House — the heart of GoCo Health Innovation City — has now been inaugurated. Simultaneously, …  

More news...

Sahlgrenska Academy

© University of Gothenburg
PO-Box 100, S-405 30 Gothenburg, Sweden
Phone: 00 46 31 786 0000

About the website

Elin Lindström is editor for Akademiliv.
Please feel free to send your ideas and comments to akademiliv@gu.se

Sign up for the Akademiliv newsletter:

Send you tips to Akademiliv

Do you have a suggestion for news, grants, seminars or an education?
Send an email to Elin Lindström Claessen